MedTrace Logo

Analysis of the Different Strategies for Revascularization of the Lower Limbs by Peripheral Angioplasty

NCT05155462 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2021-12-13

No results posted yet for this study

Summary

Peripheral arterial disease (PAD) caused by atherosclerosis causes damage to the arteries originating in the aorta (descending) from the iliacs to the extremities of the lower limbs. It causes significant morbidity and mortality. Percutaneous revascularization plays a key role in the management of these patients. Many percutaneous treatment options have been developed: arteriectomy, naked stents, active balloons and active stents. Of these, only paclitaxel-active stents were successful in reducing the rates of restenosis and reoperation in patients with superficial femoral artery injury.The main objective is to study symptomatic improvement at 1 year of patients treated with revascularization of the lower limbs.

Conditions

  • Peripheral Arterial Disease
  • Angioplasty

Interventions

OTHER

One or two phone call

Phone call to collect patient data

Sponsors & Collaborators

  • European Clinical Trial Experts Network

    collaborator OTHER

  • Ramsay Générale de Santé

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-09
Primary Completion
2020-04-09
Completion
2021-12-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155462 on ClinicalTrials.gov